Pure Global AI
NMPB Document

FM/G/01/01; FM/G/03/04; FM/R/01/02; FM/R/01/03 (printed compilation codes)

موجهات ادراج المصانع الاجنبية بالمجلس القومي للأدوية والسموم — limited medical-supplies context
SudanNational Medicines and Poisons Board / Federal Ministry of HealthRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

Document identity

موجهات ادراج المصانع الاجنبية بالمجلس القومي للأدوية والسموم — limited medical-supplies context is published by National Medicines and Poisons Board / Federal Ministry of Health. This document is identified by its title; no separate official document code is recorded.

Instrument
Document
Full name
FM/G/01/01; FM/G/03/04; FM/R/01/02; FM/R/01/03 (printed compilation codes)
Category
Registration
Source links
Source publication
Arabic / English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

موجهات ادراج المصانع الاجنبية بالمجلس القومي للأدوية والسموم — limited medical-supplies context

Complete four-page official compilation: two-page Arabic foreign-factory listing guidance and Arabic/English 20-country SRA annexes, all carrying issue date 27 March 2023 and printed controlled-copy expiry of 27 March 2026. Only section 5 on physical page 2 explicitly includes medical-supplies factories: factories already listed in specified other activities and rejected for medicine manufacture are withdrawn together with previously registered products; factories also producing medicines are not listed in the specified other activities before the medicines-factory decision. This limited mixed-activity condition is not a general MD registration or variation rule. Medicine, biological and antiserum requirements and the SRA annex are retained as source context; their blanket applicability to MD/IVD is not established. Inconsistent printed main-page codes are retained. The annex says it will be updated periodically; the current list, newer controlled guidance and position in 2026 remain unverified.

This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.